Peripheral Blood Smear Atypical Lymphocytes Association With Covid-19 Mortality
Main Article Content
Abstract
Introduction: COVID-19 disease is currently pandemic, and its prevalence in Saudi Arabia is concerning. The SARS-CoV-2 virus primarily affects the lungs, but it also affects the haematopoietic system. The atypical lymphocytes on peripheral blood film that have a distinct morphological appearance were of particular interest in this study. Our goal was to see a link between atypical lymphocytes and COVID-19 patient mortality. Methods: This four-month single-centered prospective descriptive study was conducted in Makkah, Saudi Arabia. COVID-19 patients of both genders were randomly selected based on inclusion criteria. The data from the patient’s electronic medical record was extracted. All patients’ peripheral blood film parameters were recorded on days 3, 7, and 14 after admission. The statistical data was analysed using SPSS version 23. The Fisher’s exact test was used to determine the relationship with mortality. A p value of 0.05 was considered significant. Results: The total number of cases enrolled in the study was 226. The patients’ average age was 58 years (SD 0.5289). On the third day of admission, 88.2 % of patients with COVID-19 had atypical lymphocytes, with a mean of 2.35 ± 0.927. A significant correlation (p < 0.001) exists between atypical lymphocytes decreasing percentage number on the 3rd, 7th, and 14th days of admission and death.
Conclusion: The decrease in the number of atypical lymphocytes on peripheral blood film has a significant association with the patients’ mortality. This fact can be used to develop a tailored management strategy based on the observation of peripheral blood film.
Downloads
Article Details
References
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020; 34:101623. doi: 10.1016/j.tmaid.2020.101623
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5
Karamloo F, König R. SARS-CoV-2 immunogenicity at the crossroads. Allergy. 2020 ;75(7):1822-24. doi: 10.1111/all.14360
Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation, and intervention. Nat Rev Immunol. 2020;20 (6):363-74. doi: 10.1038/s41577-020-0311-8
Jiang Y, Wei X, Guan J, Qin S, Wang Z, Lu H, et al. COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential. Clin Immunol. 2020; 218:108516. doi: 10.1016/j.clim.2020.108516.
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71(15):762-8. doi: 10.1093/cid/ciaa248.
Gerard D, Henry S, Thomas B. SARS-CoV-2: a new aetiology for atypical lymphocytes Br J Haematol. 2020; 189 (5): 845. doi: 10.1111/bjh.16730
Hermelin D, on Twitter: “Every single peripheral smear I have viewed for an acute COVID-19 admission has # covicytes”. https://twitter.com/hermelinmd/status/ 1281024 817597161473? lang = en. accessed online on March 7,2021.
El Jamal SM, Salib C, Stock A, Uriarte-Haparnas NI, Glicksberg BS, Teruya-Feldstein J, et al. Atypical lymphocyte morphology in SARS-CoV-2 infection. Pathol Res Pract. 2020;216 (9): 153063. doi: 10.1016/j.prp.2020.153063
Feder HM Jr, Rezuke WN. Infectious mononucleosis diagnosed by Downey cells: sometimes the old ways are better. Lancet 2020;395(10219):225. doi: 10.1016/S0140-6736(19)32962-9.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395 (10223):507-13. doi: 10.1016/S0140-6736(20)30211-7
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA.2020; 323(11):1061–9. doi: 10.1001/jama.2020.1585.
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020; 75(7):1730-41. doi: 10.1111/all.14238
Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, et al. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis. J Clin Med. 2020;9(4):941. doi: 10.3390/jcm9040941.
Wang F, Nie J, Wang H, Zhao Q, Xiong Y, Deng L, et al. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis. 2020; 221(11):1762-69. doi: 10.1093/infdis/jiaa150.
Imran Nazir, Mansour Al Ghamedi, Waleed AM Ahmed, Hanan MM Abdullahi, Mohammad A Farid, Khalid Khalil, et al. International journal of current medical and pharmaceutical research. International Journal of Current Medical and Pharmaceutical Research. 2020; 6, (12): 5422-27.
Son KB, Lee TJ, Hwang SS. Disease severity classification and COVID-19 outcomes, Republic of Korea. Bull World Health Organ. 2021; 99(1):62-66. doi: 10.2471/BLT.20.257758
Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020; 58:1131–4. doi: 10.1515/cclm-2020-0198.
Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med. 2020; 58:1063–9. doi: 10.1515/cclm-2020-0240.
Shrotri M, van Schalkwyk MCI, Post N, Eddy D, Huntley C, Leeman D, et al. T cell response to SARS-CoV-2 infection in humans: A systematic review. PLoS One. 2021;16(1): e0245532. doi: 10. 1371 /journal. pone. 0245532
Gelarden I, Nguyen J, Gao J, Chen Q, Morales-Nebreda L, Wunderink R, et al. Comprehensive evaluation of bronchoalveolar lavage from patients with severe COVID-19 and correlation with clinical outcomes. Human Pathology. 2021; (113): 92-103. doi: 10.1016/j.humpath.2021.04.010
Dean L. Blood Groups and Red Cell Antigens [Internet]. Bethesda (MD): National Center for Biotechnology Information (US).2005 Table 1, Complete blood count. Available from: https:// www.ncbi.nlm.nih.gov/books/NBK2263/table/ch1.T1/. Accessed on 23/10/2021.
Nazir I, Al Shareef M, Rahman SS, Imran I, Abdullah HM, Shaaban HE, Khalil K, Al Hazmi AM, Mohammed Ahmed WA, Al Kalkami A. Clinical, serological, and radiological characteristics of COVID-19 patients in Makkah, Saudi Arabia. Saudi J Health Sci. 2021; 10:14-20. doi: 10.4103/sjhs.sjhs_231_20
Chen Z, John Wherry, E. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020;20: 529–36. doi: 10.1038/s41577-020-0402-6
Sun S, Cai X, Wang H, He G, Lin Y, Lu B, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta. 2020; 507:174-80. doi: 10.1016/j.cca.2020.04.024
Weinberg SE, Behdad A, Ji P. Atypical lymphocytes in peripheral blood of patients with COVID-19. Br J Haematol. 2020;190(1):36-39. doi: 10.1111/bjh.16848
Ahmed S S, Mohammed D A, Mohammed A A. Hematological and Morphological Changes in the Peripheral Blood Smear of Patients with COVID-19. J Kermanshah Univ Med Sci. 2021;25(2):e110758. doi: 10.5812/jkums.110758.
Liu YP, Liu Y, Huang QC, Chen M, Diao B. Morphological changes of lymphocytes in peripheral blood smears of patients with covid-19. Ann Palliat Med. 9(6):4420–2 doi: 10.21037/apm-20-558
Merino A, Vlagea A, Molina Á, Egri N, Laguna J, Barrera Kevin, et al. Atypical lymphoid cells circulating in blood in COVID-19 infection: morphology, immunophenotype and prognosis value. [published online ahead of print] J Clin Pathol. 2020; jclinpath-2020-207087. doi:10.1136/ jclinpath -2020-207087
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180 (7):934-43. doi: 10.1001/jamainternmed.2020.0994.
Nazarullah A, Liang C, Villarreal A, Higgins RA, Mais DD. Peripheral Blood Examination Findings in SARS-CoV-2 Infection. Am J Clin Pathol. 2020;154(3):319-29. doi: 10.1093/ajcp/aqaa108.
Berber I, Cagasar O, Sarici A, Berber NK, Aydogdu I, Ulutas O, et al. Peripheral Blood Smear Findings of COVID-19 Patients Provide information about the Severity of the Disease and the Duration of Hospital Stay. Mediterr J Hematol Infect Dis. 2021;13(1): e 2021009. doi: 10.4084/ MJHID.2021.009.